• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Getting The Most From Your PAH Therapy

August 26, 2015 By Dr. Jeremy Feldman

We would like to introduce a new series on PulmonaryHypertensionRN.com.  This series will include periodic articles focusing on a specific therapy and how to benefit maximally and minimize side effects.

PAH medicationsLetairis (Ambrisentan) Efficacy in Pulmonary Hypertension

This medicine was first approved in 2007 based on 2 studies that both showed improvement in exercise capacity and reduction in the rate of clinical worsening over 12 weeks.  Subsequent studies have amplified on the efficacy of this medicine.  The recently reported AMBITION study powerfully showed 50% reductions in the rates of clinical decline over a several year period.  The benefits were maximal when combined with Adcirca (Tadalafil).  The combination of Letairis and Adcirca together was much more effective than either medicine alone.

Maximizing the Efficacy of Letairis

Is 10mg better than 5mg?  This is a difficult question to answer definitively.  In the 12 week study there was not a clear difference in improvement in exercise capacity.  There was a strong suggestion that the higher dose lowered pulmonary artery pressures a bit more.  In the AMBITION study, most patients were titrated to the 10mg dose over a period of a few weeks.  So our best data regarding long-term benefit is with the 10mg dose.  My practice is to start with 5mg once daily for a one to three months and reassess.  For patients that are not troubled by any side effects, then I generally move the dose to the 10mg once daily.   If patients are struggling with side effects, then I leave the dose at 5mg once daily for six months and reassess.

I generally encourage patients to take the medication with food although it may be taken on an empty stomach.  Most patients take the medication in the morning but this is not a necessity.

We have compelling data that Letairis is effective as monotherapy.  However, with the addition of the AMBITION clinical trial results, we can say with confidence that the combination of Letairis with Adcirca is even more effective.  We don’t know if Letairis combined with Revatio (Sildenafil) is as effective as Letairis combined with Adcirca.

Side Effects of Letairis

Common side effects with Letairis and strategies to deal with them are listed below.

1.     Nasal congestion.

This is the most common side effect in my experience and  is dose related (10mg results in more nasal congestion than 5mg).  For most patients it is mild in severity and requires no specific action.  For some patients it can be very frustrating (especially patients that use supplemental oxygen).  I have a series of treatments to help with nasal congestion.  First, I make sure that the nasal congestion is due to the Letairis and not seasonal allergies.  A careful history can usually tease this apart.

Once I am convinced that the nasal congestion is due to Letairis, my first line treatment is nasal saline spray.  This can be used very frequently throughout the day.  Nasal saline does not require a prescription and it is relatively inexpensive.  There are no risks to using nasal saline spray.  If this proves inadequate, then my next strategy is to try Nasal Atrovent (Ipratropium bromide spray).  Nasal Atrovent is a drying agent that may help with congestion.  This spray may be used twice daily.  Next I try Astelin (Azelastine), a nasal antihistamine.  It may be used twice daily.  If this does not help then I try a nasal steroid spray such as Flonase (Fluticasone Nasal Spray).  Flonase may be used once or twice daily.

In rare cases where the nasal congestion is very severe and not responding to treatment with the aforementioned medications, I will reduce the dose if the patient is taking 10mg.  If the patient is already taking 5mg then I will consider switching from Letairis to Opsumit (Macitentan).

2.     Flushing.

This side effect is usually mild.  Patients notice a feeling of warmth.  This may occur periodically during the day.  Some patients notice that they appear mildly red in the face during episodes.  Most importantly, the flushing sensation does not mean that anything bad is about to happen.  The first few times patients experience the sensation it can be quite surprising.  After a few episodes patients become more at ease and most do not find this a major problem.

Letairis is absolutely forbidden in women who are or may become pregnant. All women of child bearing potential must be enrolled in a monitoring program that requires a pregnancy test prior to starting therapy and each month. Effective birth control must be used.

Always consult your treating physician before making any medication decisions.

Filed Under: Pulmonary Hypertension Treatments

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

right heart catheterization to diagnose PH

Preoperative Checklist for Pulmonary Hypertension Patients

By Dr. Jeremy Feldman

Having a surgical procedure is always stressful.  Having Pulmonary Arterial Hypertension and needing a surgery is even

News about PAH

Help Arrives for Some PAH Patients Who Can’t Afford Their Medication

By Dr. Jeremy Feldman

Thousands of Pulmonary Arterial Hypertension patients across America are now experiencing a crisis.  They previously

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives